Oprah Winfrey shared a recent self-portrait on social media that highlighted the latest phase of a weight‑loss journey she has described as decades long, saying she has combined medication, exercise and dietary changes to reach her goals.
The 71‑year‑old billionaire broadcaster posed with a copy of Elizabeth Gilbert’s memoir All the Way to the River in an Instagram post promoting her book club, showing a visibly slimmer figure after she has said she lost roughly 50 pounds since beginning treatment with GLP‑1 class medications. Winfrey has publicly recounted episodes of restrictive dieting, weight regain and what she has called a lifelong "food addiction."
Winfrey has outlined the arc of her experience in pieces on her own website, magazine essays and broadcast interviews, describing early dieting attempts, a high‑profile 1988 Optifast episode on The Oprah Winfrey Show in which she displayed 67 pounds of fat in a wagon, and subsequent cycles of weight loss and regain. She said the Optifast liquid‑diet period left her metabolism disrupted and that she regained weight soon after returning to regular food.
In later years, Winfrey credited trainer Bob Greene and a private chef, Rosie Daley, with helping her reshape daily habits. She has described reaching as low as 160 pounds by 2006 after years of struggling with weight and then regaining tens of pounds amid health setbacks, including palpitations and a diagnosis of hyperthyroidism in the late 2000s.
Winfrey joined WW (formerly Weight Watchers) in 2015, bought a roughly 10 percent stake in the company and served as a prominent spokesperson; she later described losing as much as 40 pounds on the program. In statements at the time she said the points‑based system helped her change intentions about food and prioritize health over appearance.
Public attention intensified after Winfrey appeared on the red carpet for the 2023 premiere of The Colour Purple, prompting speculation about whether her changing appearance was the result of diet tracking, increased exercise or the growing use of prescription weight‑loss medications such as Ozempic and Wegovy. Winfrey initially said she did not want to take what she called the "easy way out," but in December 2023 she acknowledged using a GLP‑1 medication and said she was "done with the shaming" about seeking medical help for weight management.
Winfrey said on her podcast and in interviews that taking a GLP‑1 produced an "aha moment": she realized that what she had perceived as willpower in thinner people was often the absence of intrusive hunger thoughts, which the medications can reduce. She described the drugs as one element of a broader approach that included regular exercise and attention to diet.
The medication disclosure had corporate repercussions: Winfrey stepped down from WW’s board in early 2024 and in March 2024 said she had left the company to avoid any appearance of conflict of interest while producing a special about prescription weight‑loss drugs. She has also discussed the safety and function of the medications with medical experts on her platforms.
In January 2025, Winfrey said she had reached a goal weight of 160 pounds and continued to speak about lessons learned from her decades of dieting, including acknowledging genetic predispositions and the limits of willpower alone. She has said her aim is not simply thinness but a body that is "strong and healthy and fit."
Winfrey’s public history with weight and dieting has included candid admissions about shame and the social pressures of appearance. In essays and interviews she has described using food to numb emotions beginning in her early career, and she has repeatedly characterized her relationship with food as an addiction that has required both behavioral and medical approaches to manage.
Her recent social media appearance, and subsequent public appearances including a high‑profile wedding in Venice in June where she wore a fitted gown, have drawn continued attention to how celebrities are navigating the increasing availability of GLP‑1 medications alongside lifestyle changes. Winfrey has framed her choices in medical and personal terms, saying the availability of medically approved prescriptions for weight management felt like "relief, like redemption, like a gift" and that she no longer wished to be shamed for seeking treatment.
Medical professionals caution that GLP‑1 medications are prescription therapies intended to be used under medical supervision as part of a comprehensive plan that can include diet, exercise and monitoring for side effects. Winfrey has said she used exercise such as hiking and altered her eating patterns while taking the medication, and she has discussed the role of physicians in deciding appropriate therapy.
Winfrey’s recent post promoting her book club reaffirmed that she is publicly maintaining the regimen she has described: a combination of medical treatment when appropriate, increased physical activity and consistent dietary choices. She has continued to use her platform to discuss weight, health and the stigma that often accompanies public discussion of both.
The broadcaster’s account traces a long series of shifts between fad diets, medically supervised programs and pharmaceutical interventions, and she has repeatedly emphasized a shift in intention from achieving a particular dress size to pursuing sustained health and well‑being.